Serotonin receptor, SERT mRNA and correlations with symptoms in males with alcohol dependence and suicide

Acta Psychiatrica Scandinavica

Volumn 126, Issue 3, 2012, Pages 165-174

  Thompson, P M ^a,b   Cruz, D A ^a,b   Olukotun, D Y ^a,b   Delgado, P L ^a  

^a University of Texas Health Science Center   (United States)

^b Southwest Brain Bank   (United States)

Author keywords

Alcohol; Prefrontal cortex; Serotonin receptor 1A; Serotonin receptor 2A; Serotonin receptors; Serotonin reuptake transporter; Suicide; Symptoms

Indexed keywords

MESSENGER RNA; SEROTONIN RECEPTOR; SEROTONIN RECEPTOR 1A; SEROTONIN RECEPTOR 2A; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; AUTOPSY; BODY MASS; BRODMANN AREA 9; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMPULSIVENESS; MALE; MOOD DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SUICIDE;

ALCOHOLISM; AUTOPSY; BRAIN; CEREBRAL CORTEX; HUMANS; IMPULSIVE BEHAVIOR; MALE; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; SUICIDE;

EID: 84865090466     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01816.x     Document Type: Article

References (62)

1. Blazer DG, Kessler RC, Mcgonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994;151:979-986.
2. Kessler RC, Mcgonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19.
3. Rivara FP, Garrison MM, Ebel B, Mccarty CA, Christakis DA. Mortality attributable to harmful drinking in the United States, 2000. J Stud Alcohol 2004;65:530-536.
4. Lee BH, Kim YK. Potential peripheral biological predictors of suicidal behavior in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:842-847.
5. Tonelli LH, Stiller J, Rujescu D et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand 2008;117:198-206.
6. Lindqvist D, Janelidze S, Erhardt S, Traskman-Bendz L, Engstrom G, Brundin L. CSF biomarkers in suicide attempters - a principal component analysis. Acta Psychiatr Scand 2011;124:52-61.
7. Holmgren A, Jones AW. Demographics of suicide victims in Sweden in relation to their blood-alcohol concentration and the circumstances and manner of death. Forensic Sci Int 2010;198:17-22.
8. Underwood MD, Mann JJ, Arango V. Morphometry of dorsal raphe nucleus serotonergic neurons in alcoholism. Alcohol Clin Exp Res 2007;31:837-845.
9. Boldrini M, Underwood MD, Mann JJ, Arango V. More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res 2005;1041:19-28.
10. Bach-Mizrachi H, Underwood MD, Kassir SA et al. Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology 2006;31:814-824.
11. Ono H, Shirakawa O, Kitamura N et al. Tryptophan hydroxylase immunoreactivity is altered by the genetic variation in postmortem brain samples of both suicide victims and controls. Mol Psychiatry 2002;7:1127-1132.
12. Bonkale WL, Turecki G, Austin MC. Increased tryptophan hydroxylase immunoreactivity in the dorsal raphe nucleus of alcohol-dependent, depressed suicide subjects is restricted to the dorsal subnucleus. Synapse 2006;60:81-85.
13. Austin MC, Whitehead RE, Edgar CL, Janosky JE, Lewis DA. Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neuroscience 2002;114:807-815.
14. Stockmeier CA. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res 2003;37:357-373.
15. Underwood MD, Kassir SA, Bakalian MJ, Galfalvy H, Mann JJ, Arango V. Neuron density and serotonin receptor binding in prefrontal cortex in suicide. Int J Neuropsychopharmacol 2011;1-13.
16. Szabo Z, Owonikoko T, Peyrot M et al. Positron emission tomography imaging of the serotonin transporter in subjects with a history of alcoholism. Biol Psychiatry 2004;55:766-771.
17. Martinez D, Slifstein M, Gil R et al. Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependence. Biol Psychiatry 2009;65:175-180.
18. Koller G, Preuss UW, Bottlender M, Wenzel K, Soyka M. Impulsivity and aggression as predictors of suicide attempts in alcoholics. Eur Arch Psychiatry Clin Neurosci 2002;252:155-160.
19. Weiss D, Coccaro EF. Neuroendocrine challenge studies of suicidal behavior. Psychiatr Clin North Am 1997;20:563-579.
20. Turecki G. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J Psychiatry Neurosci 2005;30:398-408.
21. Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl):20.
22. Bowden CL, Singh V, Thompson P et al. Development of the bipolar inventory of symptoms scale. Acta Psychiatr Scand 2007;116:189-194.
23. Thompson PM, Gonzalez JM, Singh V, Schoolfield JD, Katz MM, Bowden CL. Principal domains of behavioral psychopathology identified by the Bipolar Inventory of Signs and Symptoms Scale (BISS). Psychiatry Res 2010;175:221-226.
24. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
25. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
26. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995;51:768-774.
27. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The stanley foundation brain collection and neuropathology consortium. Schizophr Res 2000;44:151-155.
28. Kingsbury AE, Foster OJ, Nisbet AP et al. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 1995;28:311-318.
29. Schroeder A, Mueller O, Stocker S et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006;7:3.
30. Rajkowska G, Goldman-Rakic PS. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. Cereb Cortex 1995;5:323-337.
31. Abasolo N, Torrell H, Roig B, Moyano S, Vilella E, Martorell L. RT-qPCR study on post-mortem brain samples from patients with major psychiatric disorders: reference genes and specimen characteristics. J Psychiatr Res 2011;45:1411-1418.
32. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-1108.
33. Erritzoe D, Frokjaer VG, Haugbol S et al. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage 2009;46:23-30.
34. George AK, Paul J, Kaimal SB, Paulose CS. Decreased cerebral cortex and liver 5-HT2A receptor gene expression and enhanced ALDH activity in ethanol-treated rats and hepatocyte cultures. Neurol Res 2010;32:510-518.
35. Underwood MD, Mann JJ, Huang YY, Arango V. Family history of alcoholism is associated with lower 5-HT2A receptor binding in the prefrontal cortex. Alcohol Clin Exp Res 2008;32:593-599.
36. Audenaert K, Van LK, Dumont F et al. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients. Eur J Nucl Med 2001;28:175-182.
37. Shelton RC, Sanders-Bush E, Manier DH, Lewis DA. Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience 2009;158:1406-1415.
38. Anisman H, Du L, Palkovits M et al. Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. J Psychiatry Neurosci 2008;33:131-141.
39. Oquendo MA, Russo SA, Underwood MD et al. Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide. Biol Psychiatry 2006;59:235-243.
40. Hadamitzky M, Koch M. Effects of acute intra-cerebral administration of the 5-HT(2A/C) receptor ligands DOI and ketanserin on impulse control in rats. Behav Brain Res 2009;204:88-92.
41. Frokjaer VG, Mortensen EL, Nielsen FA et al. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol Psychiatry 2008;63:569-576.
42. Rosell DR, Thompson JL, Slifstein M et al. Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol Psychiatry 2010;67:1154-1162.
43. Lundberg J, Borg J, Halldin C, Farde L. A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain. Psychopharmacology (Berl) 2007;195:425-433.
44. Erritzoe D, Holst K, Frokjaer VG et al. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans. J Neurosci 2010;30:3391-3397.
45. Savitz J, Lucki I, Drevets WC. 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol 2009;88:17-31.
46. Underwood MD, Mann JJ, Arango V. Serotonergic and noradrenergic neurobiology of alcoholic suicide. Alcohol Clin Exp Res 2004;5(Suppl):57S-69S.
47. Storvik M, Hakkinen M, Tupala E, Tiihonen J. 5-HT(1A) receptors in the frontal cortical brain areas in Cloninger type 1 and 2 alcoholics measured by whole-hemisphere autoradiography. Alcohol Alcohol 2009;44:2-7.
48. Arango V, Underwood MD, Gubbi AV, Mann JJ. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 1995;688:121-133.
49. Purselle DC, Nemeroff CB. Serotonin transporter: a potential substrate in the biology of suicide. Neuropsychopharmacology 2003;28:613-619.
50. Atz M, Walsh D, Cartagena P et al. Methodological considerations for gene expression profiling of human brain. J Neurosci Methods 2007;163:295-309.
51. Rademacher J, Caviness VS Jr, Steinmetz H, Galaburda AM. Topographical variation of the human primary cortices: implications for neuroimaging, brain mapping, and neurobiology. Cereb Cortex 1993;3:313-329.
52. Boldyreva GN, Zhavoronkova LA. Interhemispheric asymmetry of EEG coherence as a reflection of different functional states of the human brain. Biomed Sci 1991;2:266-270.
53. Yucel M, Stuart GW, Maruff P et al. Hemispheric and gender-related differences in the gross morphology of the anterior cingulate/paracingulate cortex in normal volunteers: an MRI morphometric study. Cereb Cortex 2001;11:17-25.
54. Li MD, Kane JK, Wang J, Ma JZ. Time-dependent changes in transcriptional profiles within five rat brain regions in response to nicotine treatment. Brain Res Mol Brain Res 2004;132:168-180.
55. Mullan M, Scibelli P, Duara R et al. Familial and population-based studies of apolipoprotein E and Alzheimer's disease. Ann N Y Acad Sci 1996;802:16-26.
56. Anji A, Kumari M, Sullivan Hanley NR, Bryan GL, Hensler JG. Regulation of 5-HT(2A) receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin. Neuropharmacology 2000;39:1996-2005.
57. Idkowiak-Baldys J, Baldys A, Raymond JR, Hannun YA. Sustained receptor stimulation leads to sequestration of recycling endosomes in a classical protein kinase C- and phospholipase D-dependent manner. J Biol Chem 2009;284:22322-22331.
58. Ozaslan D, Wang S, Ahmed BA et al. Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues. J Biol Chem 2003;278:43991-44000.
59. Yao Y, Bergold PJ, Penington NJ. Acute Ca(2+)-dependent desensitization of 5-HT(1A) receptors is mediated by activation of protein kinase A (PKA) in rat serotonergic neurons. Neuroscience 2010;169:87-97.
60. Hensler JG. Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci 2003;72:1665-1682.
61. Zhong P, Yuen EY, Yan Z. Modulation of neuronal excitability by serotonin-NMDA interactions in prefrontal cortex. Mol Cell Neurosci 2008;38:290-299.
62. Magalhaes AC, Holmes KD, Dale LB et al. CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. Nat Neurosci 2010;13:622-629.